17 / April / 2026 International programs seek scientific talent in response to US budget cuts Initiatives in countries such as Germany, France, and Brazil are increasing their support for US-based researchers seeking a more stable environment Por Samuel Fernandes
31 / March / 2026 Citations in clinical practice guidelines do not always reflect true impact of research Study identifies hidden and symbolic citation patterns that distort the measurement of scientific impact in health policies Por Editorial staff
20 / March / 2026 Netherlands to create innovation agency modeled on DARPA New institution plans to spend €500 million euros on high-risk R&D and aims to bridge the “valley of death” between research and the market Por Editorial staff
11 / March / 2026 European agencies reform research assessment to prioritize quality A study of 10 funding agencies highlights growing adoption of qualitative criteria and the discontinuation of metrics such as journal impact factors Por Editorial staff
26 / August / 2025 Location influences academic productivity in the life sciences Researchers who move to higher-performing institutions tend to publish more, according to analysis of data from 300,000 US scientists Por Editorial staff
10 / March / 2025 “Philanthropy plays a crucial role in supporting science” Philanthropic organizations set to play a growing role as budgets are cut, says France Córdova, former director of the NSF Por Bruno de Pierro
08 / January / 2025 Is American science at risk under Donald Trump? The Republican’s return to the White House has reignited concerns about the direction of science and technology policies in the US over the coming years Por Rodrigo de Oliveira Andrade
20 / September / 2024 “We want science to be done in the Amazon, not just about the Amazon” Local communities should be involved in studies carried out in the region, says Marcel Botelho, president of the Amazon Research Foundation Por Moura Leite Netto
27 / August / 2024 Support for research is key to improving health services Defining priorities and incorporating scientific findings help guide actions and strengthen health systems in Brazil Por Maritsa Carla de Bortoli
25 / June / 2024 Jorge Kalil: Making vaccines in Brazil is like David versus Goliath The country is not investing enough in the technology needed to develop and produce vaccines for the biggest threats to public health, says the former Butantan director Por Moura Leite Netto
